Company intelligence / Profile preview

Callisto Group

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Callisto Pharma Group is a leading consultancy and technical services provider to the pharmaceutical industry. It offers comprehensive support across the supply chain—including regulatory affairs, product development, licensing, pharmacovigilance, batch certification/release, importation/exportation logistics and distribution—for human and veterinary medicines as well as medical devices and related regulated products. The group holds key licenses in both the UK (MHRA) and Ireland (HPRA), enabling it to facilitate market access for clients in both regions. In 2024 it was acquired by Productlife Group.

Modalities: Small moleculeBiologicMedical deviceHerbal medicinesFood supplements
Industry: Consulting

Partnerships

Now part of Productlife Group alliance post-acquisitionNo other major partnerships disclosed publicly.

Beyond the preview

Go deeper on Callisto Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Callisto Group.

Explore the full profile